Sfoglia per Autore
Molecular Mechanisms of Cancer Progression: The Central Role of the Retinoblastoma Family Members
2017-01-01 Barbarino, M
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients
2017-01-01 Pastina, Pierpaolo; Nardone, Valerio; Croci, Stefania; Battaglia, Giuseppe; Vanni, Francesca; Bellan, Cristiana; Barbarino, Marcella; Ricci, Veronica; Costantini, Susan; Capone, Francesca; Botta, Cirino; Zarone, Mayra Rachele; Misso, Gabriella; Boccellino, Mariarosaria; Caraglia, Michele; Giordano, Antonio; Paladini, Piero; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Pirtoli, Luigi; Correale, Pierpaolo
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs
2017-01-01 Cimini, Annamaria; D’Angelo, Michele; Benedetti, Elisabetta; D’Angelo, Barbara; Laurenti, Giulio; Antonosante, Andrea; Cristiano, Loredana; Di Mambro, Antonella; Barbarino, Marcella; Castelli, Vanessa; Cinque, Benedetta; Cifone, Maria Grazia; Ippoliti, Rodolfo; Pentimalli, Francesca; Giordano, Antonio
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab
2017-01-01 Pastina, Pierpaolo; Nardone, Valerio; Battaglia, Giuseppe; Botta, Cirino; Tini, Paolo; Bellan, Cristiana; Ricci, Veronica; Barbarino, Marcella; Croci, Stefania; Caraglia, Michele; Giordano, Antonio; Cusi, MARIA GRAZIA; Pirtoli, Luigi; Pierpaolo, Correale
Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold
2014-01-01 Taddei, Maurizio; Ferrini, Serena; Giannotti, Luca; Corsi, Massimo; Manetti, Fabrizio; Giuseppe, Giannini; Loredana, Vesci; Milazzo, Ferdinando M.; Domenico, Alloatti; Guglielmi, Mario B.; Massimo, Castorina; Cervoni, Maria L.; Barbarino, Marcella; Rosanna, Fodera; Valeria, Carollo; Claudio, Pisano; Silvia, Armaroli; Walter, Cabri
Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold
2014-01-01 Giannini, G; Battistuzzi, G; Vesci, L; Milazzo, Fm; De Paolis, F; Barbarino, M; Guglielmi, ; Carollo, V; Gallo, G; Artali, R; Dallavalle, S
ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors
2014-01-01 Giannini, G.; Vesci, L.; Battistuzzi, G.; Vignola, D.; Milazzo, F. M.; Guglielmi, M. B.; Barbarino, M.; Santaniello, M.; Fantò, N.; Mor, M.; Rivara, S.; Pala, D.; Taddei, Maurizio; Pisano, C.; Cabri, W.
Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors
2012-01-01 Bargiotti, A; Musso, L; Dallavalle, S; Merlini, L; Gallo, G; Ciacci, A; Giannini, G; Cabri, W; Penco, S; Vesci, L; Castorina, M; Milazzo, Fm; Cervoni, Ml; Barbarino, M; Pisano, C; Giommarelli, C; Zuco, V; De,
Efficient organic monoliths prepared by γ-radiation induced polymerization in the evaluation of histone deacetylase inhibitors by capillary(nano)-high performance liquid chromatography and ion trap mass spectrometry
2011-01-01 Badaloni, E; Barbarino, M; Cabri, W; D'Acquarica, I; Forte, M; Gasparrini, F; Giorgi, F; Pierini, M; Simone, P; Ursini, O; Villani, C.
Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90
2011-01-01 Baruchello, R; Simoni, D; Grisolia, G; Barbato, G; Marchetti, P; Rondanin, R; Mangiola, S; Giannini, G; Brunetti, T; Alloatti, D; Gallo, G; Ciacci, A; Vesci, L; Castorina, M; Milazzo, Fm; Cervoni, Ml; Guglielmi, Mb; Barbarino, M; Foderà, R; Pisano, C; Cabri, W.
Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine
2010-01-01 Pisano, C; Vesci, L; Milazzo, Fm; Guglielmi, Mb; Foderà, R; Barbarino, M; D'Incalci, M; Zucchetti, M; Petrangolini, G; Tortoreto, M; Perego, P; Zuco, V; Orlandi, A; Passeri, D; Carminati, P; Cavazza, C; Zunino, F.
Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors
2009-01-01 Dallavalle, S; Cincinelli, R; Nannei, R; Merlini, L; Morini, G; Penco, S; Pisano, C; Vesci, L; Barbarino, M; Zuco, V; De Cesare, M; Zunino, F.
Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence
2007-01-01 Hanessian, S; Auzzas, L; Giannini, G; Marzi, M; Cabri, W; Barbarino, M; Vesci, L; Pisano, C.
Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response
2005-01-01 Zuco, V; Zanchi, C; Lanzi, C; Beretta, Gl; Supino, R; Pisano, C; Barbarino, M; Zanier, R; Bucci, F; Aulicino, C; Carminati, P; Zunino, F.
Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method
2004-01-01 Stano, P; Bufali, S; Pisano, C; Bucci, F; Barbarino, M; Santaniello, M; Carminati, P; Luisi, Pl.
Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (ADP-ribose) polymerase inhibitor
2003-01-01 Tentori, L.; Portarena, I.; Barbarino, M.; Balduzzi, A.; Levati, L.; Vergati, M.; Biroccio, A.; Gold, B.; Lombardi, M. L.; Graziani, G.
Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells
2003-01-01 Di Gennaro, E; Barbarino, M; Bruzzese, F; De Lorenzo, S; Caraglia, M; Abbruzzese, A; Avallone, A; Comella, P; Caponigro, F; Pepe, S; Budillon, A
CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway
2002-01-01 Graziani, G; Tentori, L; Portarena, I; Barbarino, M; Tringali, G; Pozzoli, G; Navarra, P.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Molecular Mechanisms of Cancer Progression: The Central Role of the Retinoblastoma Family Members | 1-gen-2017 | Barbarino, M | - | |
| Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients | 1-gen-2017 | Pastina, Pierpaolo; Nardone, Valerio; Croci, Stefania; Battaglia, Giuseppe; Vanni, Francesca; Bellan, Cristiana; Barbarino, Marcella; Ricci, Veronica; Costantini, Susan; Capone, Francesca; Botta, Cirino; Zarone, Mayra Rachele; Misso, Gabriella; Boccellino, Mariarosaria; Caraglia, Michele; Giordano, Antonio; Paladini, Piero; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Pirtoli, Luigi; Correale, Pierpaolo | - | |
| Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs | 1-gen-2017 | Cimini, Annamaria; D’Angelo, Michele; Benedetti, Elisabetta; D’Angelo, Barbara; Laurenti, Giulio; Antonosante, Andrea; Cristiano, Loredana; Di Mambro, Antonella; Barbarino, Marcella; Castelli, Vanessa; Cinque, Benedetta; Cifone, Maria Grazia; Ippoliti, Rodolfo; Pentimalli, Francesca; Giordano, Antonio | - | |
| Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab | 1-gen-2017 | Pastina, Pierpaolo; Nardone, Valerio; Battaglia, Giuseppe; Botta, Cirino; Tini, Paolo; Bellan, Cristiana; Ricci, Veronica; Barbarino, Marcella; Croci, Stefania; Caraglia, Michele; Giordano, Antonio; Cusi, MARIA GRAZIA; Pirtoli, Luigi; Pierpaolo, Correale | - | |
| Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold | 1-gen-2014 | Taddei, Maurizio; Ferrini, Serena; Giannotti, Luca; Corsi, Massimo; Manetti, Fabrizio; Giuseppe, Giannini; Loredana, Vesci; Milazzo, Ferdinando M.; Domenico, Alloatti; Guglielmi, Mario B.; Massimo, Castorina; Cervoni, Maria L.; Barbarino, Marcella; Rosanna, Fodera; Valeria, Carollo; Claudio, Pisano; Silvia, Armaroli; Walter, Cabri | - | |
| Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold | 1-gen-2014 | Giannini, G; Battistuzzi, G; Vesci, L; Milazzo, Fm; De Paolis, F; Barbarino, M; Guglielmi, ; Carollo, V; Gallo, G; Artali, R; Dallavalle, S | - | |
| ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors | 1-gen-2014 | Giannini, G.; Vesci, L.; Battistuzzi, G.; Vignola, D.; Milazzo, F. M.; Guglielmi, M. B.; Barbarino, M.; Santaniello, M.; Fantò, N.; Mor, M.; Rivara, S.; Pala, D.; Taddei, Maurizio; Pisano, C.; Cabri, W. | - | |
| Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors | 1-gen-2012 | Bargiotti, A; Musso, L; Dallavalle, S; Merlini, L; Gallo, G; Ciacci, A; Giannini, G; Cabri, W; Penco, S; Vesci, L; Castorina, M; Milazzo, Fm; Cervoni, Ml; Barbarino, M; Pisano, C; Giommarelli, C; Zuco, V; De, | - | |
| Efficient organic monoliths prepared by γ-radiation induced polymerization in the evaluation of histone deacetylase inhibitors by capillary(nano)-high performance liquid chromatography and ion trap mass spectrometry | 1-gen-2011 | Badaloni, E; Barbarino, M; Cabri, W; D'Acquarica, I; Forte, M; Gasparrini, F; Giorgi, F; Pierini, M; Simone, P; Ursini, O; Villani, C. | - | |
| Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90 | 1-gen-2011 | Baruchello, R; Simoni, D; Grisolia, G; Barbato, G; Marchetti, P; Rondanin, R; Mangiola, S; Giannini, G; Brunetti, T; Alloatti, D; Gallo, G; Ciacci, A; Vesci, L; Castorina, M; Milazzo, Fm; Cervoni, Ml; Guglielmi, Mb; Barbarino, M; Foderà, R; Pisano, C; Cabri, W. | - | |
| Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine | 1-gen-2010 | Pisano, C; Vesci, L; Milazzo, Fm; Guglielmi, Mb; Foderà, R; Barbarino, M; D'Incalci, M; Zucchetti, M; Petrangolini, G; Tortoreto, M; Perego, P; Zuco, V; Orlandi, A; Passeri, D; Carminati, P; Cavazza, C; Zunino, F. | - | |
| Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors | 1-gen-2009 | Dallavalle, S; Cincinelli, R; Nannei, R; Merlini, L; Morini, G; Penco, S; Pisano, C; Vesci, L; Barbarino, M; Zuco, V; De Cesare, M; Zunino, F. | - | |
| Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence | 1-gen-2007 | Hanessian, S; Auzzas, L; Giannini, G; Marzi, M; Cabri, W; Barbarino, M; Vesci, L; Pisano, C. | - | |
| Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response | 1-gen-2005 | Zuco, V; Zanchi, C; Lanzi, C; Beretta, Gl; Supino, R; Pisano, C; Barbarino, M; Zanier, R; Bucci, F; Aulicino, C; Carminati, P; Zunino, F. | - | |
| Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method | 1-gen-2004 | Stano, P; Bufali, S; Pisano, C; Bucci, F; Barbarino, M; Santaniello, M; Carminati, P; Luisi, Pl. | - | |
| Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (ADP-ribose) polymerase inhibitor | 1-gen-2003 | Tentori, L.; Portarena, I.; Barbarino, M.; Balduzzi, A.; Levati, L.; Vergati, M.; Biroccio, A.; Gold, B.; Lombardi, M. L.; Graziani, G. | - | |
| Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells | 1-gen-2003 | Di Gennaro, E; Barbarino, M; Bruzzese, F; De Lorenzo, S; Caraglia, M; Abbruzzese, A; Avallone, A; Comella, P; Caponigro, F; Pepe, S; Budillon, A | - | |
| CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway | 1-gen-2002 | Graziani, G; Tentori, L; Portarena, I; Barbarino, M; Tringali, G; Pozzoli, G; Navarra, P. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile